The conformational changes of Zika virus methyltransferase upon converting SAM to SAH

Han Zhou,Fenghua Wang,Haofeng Wang,Cheng Chen,Tianqing Zhang,Xu Han,Deping Wang,Chen Chen,Chen Wu,Wei Xie,Zefang Wang,Lei Zhang,Lanfeng Wang,Haitao Yang
DOI: https://doi.org/10.18632/oncotarget.14780
2017-01-21
Oncotarget
Abstract:An outbreak of Zika virus (ZIKV) infection has been reported in South and Central America and the Caribbean. Neonatal microcephaly potentially associated with ZIKV infection has already caused a public health emergency of international concern. Currently, there are no clinically effective vaccines or antiviral drugs available to treat ZIKV infection. The methyltransferase domain (MTase) of ZIKV nonstructural protein 5 (NS5) can sequentially methylate guanine N-7 and ribose 2'-O to form m7NGpppA2'Om cap structure in the new RNA transcripts. This methylation step is crucial for ZIKV replication cycle and evading the host immune system, making it a target for drug design. Here, we present the 1.76 Å crystal structure of ZIKV MTase in complex with the byproduct SAH, providing insight into the elegant methylation process, which will benefit the following antiviral drug development.
What problem does this paper attempt to address?